Medication info
RotiBeul Tablet 10/10 mg

RotiBeul Tablet 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
Yellow, rectangular film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP × 3], 30 tablets/bottle
Approval status
Active

MFDS item code 202004600 · Approved 2020.06.23 · Insurance code 642707000

Summary

Main use
For the treatment of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine should be administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

For the treatment of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL cholesterol
  • elevated Apo B
  • increased triglycerides
  • increased non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used to lower elevated total cholesterol, bad LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and to increase good HDL cholesterol levels. It is primarily administered as an adjunct to dietary therapy aimed at improving blood lipid levels and is suitable for patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. Prior to treatment initiation, secondary causes of dyslipidemia such as diabetes and hypothyroidism should be assessed and treated if necessary, and regular blood tests are recommended to confirm accurate lipid levels. Additionally, this medication is used when dietary measures and other non-drug treatments are insufficiently effective. It helps to improve blood lipid levels and reduce the risk of cardiovascular disease.

How to take

Adult dose

This medicine should be administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication contains the ingredients rosuvastatin and ezetimibe and is primarily used for the treatment of hypercholesterolemia. Before taking this medication, it should be confirmed whether there is a risk of muscle pain or myopathy, particularly serious muscle conditions such as rhabdomyolysis. If severe muscle pain or weakness occurs, accompanied by fever and muscle pain, the doctor should be notified immediately, and if necessary, muscle enzyme levels may be tested to halt dosing. For patients with poor liver function or a history of liver disease, liver function tests should be carried out periodically before and during the use of this medication, and dosing should be halted if liver enzyme levels rise significantly. This medication should not be used in patients with severely impaired kidney function, those with muscle disorders, pregnant women, or breastfeeding women. This medication may interact with other drugs, so caution is needed, especially when used in combination with cyclosporine, fibrate drugs, anticoagulants, and certain antibiotics. Appropriate monitoring should be undertaken after consulting a doctor when used in conjunction. This medication contains lactose, so patients with lactose intolerance should be cautious when taking it. Elderly patients or those with liver disease, kidney impairment, hypothyroidism, and alcohol use disorder need to be especially careful while taking this medication, and they should be administered as directed by a physician. Women who are pregnant or who may become pregnant must ensure appropriate contraception, and if pregnancy is confirmed, dosing should be discontinued immediately. While taking this medication, side effects such as headaches, dizziness, indigestion, muscle pain, increased liver enzymes, edema, and others may occur, so if symptoms are severe or persistent, consult a doctor. Safety in children and adolescents has not been sufficiently established, so this medication is not recommended for pediatric patients. Caution is required when driving or operating machinery as dizziness may occur.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood sugar, increased blood CPK, chest discomfort, dizziness, lethargy, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, dermatophyte infections of nails, soft tissue infections, hepatic steatosis, liver impairment, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased blood alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, kidney dysfunction, benign esophageal neoplasm, chest pain, strange sensations, drug intolerance, irritable bowel syndrome, colon polyps, esophagitis, angioedema, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, memory decline, forgetfulness, amnesia, memory disorders, confusion, myasthenia gravis, ocular myasthenia, elevated CK, chest pain, cough, myalgia, dizziness, weakness, arthralgia, fatigue, numbness, sensory abnormalities, chest discomfort, anorexia, abdominal bloating, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, elevated blood creatinine, fatigue, abdominal pain, diarrhea, viral infections, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, cholelithiasis, cholecystitis, tremors, epigastric pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, nasal discharge, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival congestion, renal failure, abnormal liver function, increased blood creatinine, elevated blood pressure, increased blood urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius, avoiding excessively hot or cold locations.

Appearance and packaging

Appearance

Yellow, rectangular film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.